Recent advertising figures indicate the makers of the heartburn drug Zantac and its generic equivalents will soon be facing an onslaught of lawsuits, as personal injury lawyers have begun the process of rounding up clients.
NORMAN, Okla. (Legal Newsline) – Oklahoma’s landmark verdict in its opioid case against Johnson & Johnson does not mean the company must pump billions of dollars into the state over the next 30 years, a judge ruled Friday.
CLEVELAND (Legal Newsline) – Is he blowing the whistle or passing the buck? A badge-flashing, gun-toting bulldog, or an ineffective bureaucrat? Is he defined by an appearance on "60 Minutes," or the fact that trial lawyers pay him $500 for 60 minutes of his time?
WASHINGTON (Legal Newsline) – The Federal Trade Commission says lawyers and legal advertisers looking for plaintiffs to sue drug companies are making false claims in their TV ads, as well as possibly scaring viewers into stopping taking their medications.
CINCINNATI (Legal Newsline) – A federal appeals court has turned away an attempt to halt the first federal opioid trial by ruling Thursday against Ohio Attorney General Dave Yost, who is concerned cities and counties in his state have usurped his authority.
WASHINGTON (Legal Newsline) – As a federal agency considers whether lawyers are illegally frightening potential clients who see their television commercials, research shows drugs like Invokana and Truvada are among the most popular subjects of lawyer spending.
CLEVELAND (Legal Newsline) – The judge overseeing nearly 2,000 opioid lawsuits must address concerns that the cases over which he is presiding are an improper power grab by plaintiffs lawyers who signed up cities and counties as clients.
During the boom of the addiction crisis in America, opioid distributors were told to figure out a system for identifying suspicious orders but what they came up with could never be given a stamp of approval from federal regulators – even if they asked.
Now, Rannazzisi is helping private lawyers pin the blame squarely on manufacturers and distributors of opioids, as well as pharmacies. A post-DEA alliance with trial lawyers has been worth six figures for Rannazzisi, who has been hailed as a whistleblower by those cheering attempts to prosecute the opioid industry for the nation’s addiction crisis.
WASHINGTON (Legal Newsline) – Last week, a U.S. Senate committee strengthened one of the many bills that attempt to regulate chemicals known as PFAS, as critics continue to fight the idea that enough is known about them to pass legislation.
WASHINGTON (Legal Newsline) – They have a catchy, sinister-sounding nickname and have caught the attention of lawyers and politicians. But what these “forever chemicals” don’t have is a known toxicity level.
WASHINGTON (Legal Newsline) – As Congress vilifies chemicals known as PFAS, some question whether the research upon which lawmakers – and trial lawyers – are relying shows that anyone has actually been harmed by them.
NEW YORK (Legal Newsline) – The top lawyers of 15 states are again asking a federal judge to reject the legal strategy used by public officials and the private attorneys with whom they’ve teamed to sue the energy industry over alleged effects of climate change.
SAN FRANCISCO (Legal Newsline) – Two days after local officials in the Boulder, Colo., area filed a lawsuit that attempts to hold large energy companies liable for the alleged effects of global warming, the state’s top lawyer showed that she disagrees with their legal argument by voicing her opposition to similar lawsuits in California.
WASHINGTON (Legal Newsline) – As the director of a federal consumer protection agency seemingly fights for his job, he has gone forth with plans to finalize a controversial rule – and a court challenge seems imminent.
WASHINGTON – Under threat of a presidential veto, the U.S. House of Representatives on Jan. 8 passed a bill that targets class action lawsuits and the asbestos injury compensation system. H.R. 1927 combines the Fairness in Class Action Litigation Act and the Furthering Asbestos Claim Transparency Act, or FACT Act. After hours of debate and the rejection of several Democrat-proposed amendments, the Republican-controlled House passed the bill in a 211-188.